The University of Maryland has assembled an interprofessional team of research scientists from its campuses in Baltimore and College Park for a center of excellence.

$1.1 million, two-year contract will study the “switchability” of anti-epileptic drugs and address safety and effectiveness concerns

Researcher focuses on drug transporters, enhancing drug bioavailability, and problems with drug distribution mechanisms